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Abstract 
Biodegradation of β-blocker atenolol was investigated using an enriched nitrifying culture at 
controlled ammonium concentration and without ammonium addition. Analysis of the kinetics 
and structural elucidation of biodegradation products showed that atenolol biodegradation was 
found to be linked to the activity of nitrifying bacteria in the presence of ammonium. Atenolol 
was degraded cometabolically by ammonia-oxidizing bacteria (AOB), likely due to a broad 
substrate range of ammonia monooxyenase (AMO). Four products were formed during atenolol 
biodegradation with ammonia oxidation, including P267 (atenolol acid) and three new products 
P117 (1-isopropylamino-2-propanol), P167 (1-amino-3-phenoxy-2-propanol), and an unknown 
product P227 with a nominal molecular mass of 227. In comparison, only P267 and P227 were 
identified during atenolol biodegradation without ammonia oxidation. Follow-up experiments 
using atenolol acid as the parent compound indicated the formation of products P117, P167 and 
P227 in the presence of ammonium. Based on the products identified, a tentative biodegradation 
pathway of atenolol is suggested, which involves two steps independent of the presence of 
ammonium: i) microbial amide-bond hydrolysis to carboxyl group and formation of P267 
(atenolol acid) and ii) a possible formation of P227 with its unidentified structure and other two 
cometabolically induced reactions: iii) breakage of ether bond in the alkyl side chain and 
formation of P117 and iv) a minor pathway through N-dealkylation and loss of acetamide moiety 
from the aromatic ring, yielding P167. This study provided an important insight regarding the 
biotransformation pathways under different metabolic conditions.  
 
Keywords: Biodegradation; Ammonia oxidizing bacteria (AOB); Atenolol; Cometabolism; 
Transformation products; Pathways 
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1. Introduction 
The occurrence of pharmaceutical residues in wastewater treatment plant (WWTP) effluents 
has attracted growing scientific and regulatory concerns during the last decade due to their 
potential detrimental effects on the ecosystem [1-3]. Conventional WWTPs are primarily 
designed to remove easily and moderately biodegradable carbon, nitrogen and phosphorus 
compounds and microbiological organisms, while pharmaceuticals and other trace organic 
contaminants are only partially transformed [3-6].  
Enhanced removal of pharmaceuticals was observed in nitrifying activated sludge system [7, 
8]. Another study showed that the oxidative removal of trace organic contaminants correlated 
with the removal of ammonium (NH4+-N) [9]. Ammonia oxidizing bacteria (AOB) in the 
nitrifying activated sludge are able to degrade a range of aromatic compounds due to its non-
specific enzyme ammonium monooxygenase (AMO) [10, 11], following cometabolism in the 
obligatory presence of a growth substrate such as ammonium [12]. AMO was capable of 
oxidizing a broad range of aromatic substrates [10, 13], probably due to the mechanism of 
reaction with oxygenated form of AMO [14]. On the other hand, heterotrophs also showed the 
ability to degrade some pharmaceuticals (ketoprofen, acetaminophen) following metabolic 
biodegradation pathways [15, 16]. However, the underlying biodegradation mechanisms of 
pharmaceuticals in nitrifying sludge are still ambiguous and need to be elucidated. Given that 
biodegradation products formed could be more persistent and toxic than their parent compound 
and related to the operating conditions [17, 18], it is important to study the biotransformation 
pathways of pharmaceuticals under different metabolic conditions and identify the microbial 
communities involved. 
Atenolol is one of the most commonly prescribed β-blockers, used in antihypertensive, 
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antianginal and antiarrhythmic treatment [19]. After human consumption it is excreted mainly 
unchanged, leading to its frequent detection in raw wastewater and effluents of the WWTPs [20]. 
Although the toxicity of atenolol is negligible, it may have a synergistic effect in the presence of 
other β-blockers in the environment [21]. Previously, amide-bond hydrolysis and formation of 
atenolol acid was reported as the main biodegradation pathway of atenolol in conventional 
activated sludge and membrane bioreactor sludge [22]. Biodegradation of atenolol by nitrifying 
sludge was linked to the presence of AOB and heterotrophs [23]. However, biodegradation 
products and pathways of atenolol in the nitrifying activated sludge remain unclear. 
The main objectives of this study are to investigate the biodegradation mechanisms of 
atenolol by nitrifying sludge, to identify its biodegradation products and to propose possible 
biodegradation pathways under different metabolic conditions. Batch experiments were 
conducted at controlled ammonium concentration and without ammonium addition to investigate 
cometabolic and metabolic biodegradation of atenolol. Structural identification of the 
biodegradation products was performed to help elucidate the biodegradation pathways of 
atenolol. 
 
2. Materials and methods 
 
2.1 Chemicals 
Atenolol (≥98%), atenolol acid, allylthiourea (ATU, 98%) and all the other organic solvents 
(LC grade) were purchased from Sigma-Aldrich, Australia. 1-isopropylamino-2-propanol (95%) 
and 1-amino-3-phenoxy-2-propanol (94%) were obtained from Enamine Ltd. The individual 
standard stock solution of atenolol was prepared in methanol at 1 g L-1 and stored at -20 °C. 
  
 
5 
Working standards were obtained through dilution of the standard stock solution with purified 
water, obtained from a Milli-Q system (Millipore, Inc.). Atenolol feed solution for batch 
biodegradation experiments was prepared at 1 g L-1 in Milli-Q water.  
 
2.2 Culture enrichment 
A lab-scale sequencing batch reactor (SBR) seeded with activated sludge from a domestic 
wastewater treatment plant in Brisbane was used to enrich the nitrifying cultures, consisting of 
AOB and nitrite oxidizing bacteria (NOB). It was operated on a 6-h cycle consisting of 260 min 
aerobic feeding, 30 min aerobic reacting, 1 min wasting, 60 min settling and 9 min decanting 
periods. During each cycle, 2 L synthetic wastewater was fed into the reactor resulting in a 
hydraulic retention time (HRT) of 24 h. The solid retention time (SRT) was kept at 15 days. 
Reactor pH and dissolved oxygen (DO) were monitored using miniCHEM meters and controlled 
in the range of 7.5-8.0 and 2.5-3.0 mg L-1, respectively, with programmed logic controllers 
(PLC). The synthetic wastewater for the AOB+NOB culture contained per liter [24]: 5.63 g of 
NH4HCO3 (1 g NH4+-N), 5.99 g of NaHCO3, 0.064 g of each of KH2PO4 and K2HPO4 and 2 mL 
of a trace element solution. The trace element stock solution contained: 1.25 g L-1 EDTA, 0.55 g 
L-1 ZnSO4·7H2O, 0.40 g L-1 CoCl2·6H2O, 1.275 g L-1 MnCl2·4H2O, 0.40 g L-1 CuSO4·5H2O, 
0.05 g L-1 Na2MoO4·2H2O, 1.375 g L-1 CaCl2·2H2O, 1.25 g L-1 FeCl3·6H2O and 44.4 g L-1 
MgSO4·7H2O. 
The reactor was operated in steady state for more than 10 months, with 98.6 ± 3.5% 
conversion of NH4+ to NO3-, at the time of the batch tests. The mixed liquor volatile suspended 
solids (MLVSS) concentration was stable at 1437.6 ± 112.9 mg L-1 (mean and standard errors, 
respectively, n=10). Characterization of the biomass composition using fluorescence in situ 
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hybridization (FISH) indicated that 46 ± 6% (n=20) of the bacterial populations were ammonia-
oxidizing beta-proteobacteria and 38 ± 5% (n=20) of the bacterial populations belonged to the 
Nitrospira genera (nitrite oxidizers). We also conducted 16S rRNA gene sequencing to identify 
the predominant AOB species of the enriched nitrifying culture. The result revealed that the 
AOB in the sludge were dominated by Nitrosomonadaceae (∼80%). 
 
2.3 Atenolol biodegradation experiments 
Biodegradation experiments were conducted in 4 L beakers, wrapped in aluminum foil. 2.5 
L freshly enriched nitrifying culture taken from the lab-scale SBR was used as the inoculum. To 
provide fundamental understanding of atenolol biodegradation and identify possible 
biodegradation products, they were amended with a relatively high concentration of atenolol, i.e., 
15 mg L-1, due to the fact that the products may not be fully identified under low concentration 
condition [22]. The detailed batch experimental designs are provided in Table S1 in Supporting 
information (SI), consisting of five types of experimental protocols in duplicates for each. 
Experimental protocol 1 was to assess biodegradation of atenolol in the presence of ammonium 
with the addition of ammonium at 50 mg-N L-1. This concentration was kept constant during the 
experiment through automatic addition of a mixture of ammonium bicarbonate and sodium 
bicarbonate with the purposes to provide ammonium and to adjust the pH. Experimental protocol 
2 was to assess biodegradation of atenolol in absence of ammonium. The operational conditions 
were same as those in the experimental protocol 1, except that the culture did not contain any 
ammonium initially and no ammonium bicarbonate was supplied. Experimental protocol 3 was 
to study the contribution of heterotrophs on atenolol biodegradation with the addition of AMO 
inhibitor. ATU was reported to be a strong and selective inhibitor of ammonia oxidation [25], 
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probably by chelating the copper of AMO active site [26]. It was widely applied as a common 
method to inhibit AOB activity although it was not confirmed whether ATU would affect all 
copper-containing enzymes [23]. 30 mg L-1 ATU was added before starting the experiment. 
Experimental protocols 4 and 5 were used as control to assess the contribution of abiotic and 
hydrolytic degradation, respectively. For protocol 4, the biomass was autoclaved at 121 °C and 
103 kPa for 30 minutes to ensure entire inactivation of the microbial activity [27]. For protocol 5, 
hydrolysis of atenolol was studied in Milli-Q water. DO and pH were maintained at the same 
levels as in the parent SBR, i,e, 2.5-3.0 mg L-1 and 7.5-8.0, respectively, which would not affect 
the dynamics of the microbial community structure in the batch experiment. The MLVSS 
concentration was kept at approximately 1 g L-1 in all experiments except the hydrolytic control. 
The batch experimental reactors were mixed using a magnetic stirrer at 250 rpm, and aerated 
during the entire experimental period. Samples were collected periodically for atenolol and the 
biodegradation products analysis.  
 
2.4 Analytical methods 
Samples from the biodegradation experiments were centrifuged at 12000 g for 5 min and 1 
mL supernatant was used for structural elucidation of the biodegradation products. All samples 
were diluted 100 times for accurate quantification due to the limitation of the sensitivity and the 
range of the calibration curve (1-200 µg L-1). Samples were analyzed with an ultra-fast liquid 
chromatography (UFLC) (Shimadzu, Japan) coupled with a 4000 QTRAP hybrid triple 
quadruple-linear ion trap mass spectrometer (QqLIT-MS) equipped with a Turbo Ion Spray 
source (Applied Biosystems-Sciex, USA). LC separation was performed using an Alltima C18 
column at 40 °C, supplied by Alltech Associates Inc (USA). The injection volume was 20 µL. 
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Atenolol and its biodegradation products were analyzed in positive electrospray ionization (ESI+) 
mode with a mobile phase containing (A) H2O and (B) CH3CN at 1 mL min-1. The gradient 
elution procedure was conducted as follows: it was linearly increased to 5% B after 0.5 min, 
further increased to 20% B for 12.5 min, increased to 50% B within 5 min, increased to 100% B 
for 2 min, kept constant for 4 min and finally was decreased to 5% B for 1 min. The total running 
time including the conditioning of the column to the initial conditions was 27 min. The turbo ion 
spray source was operated in ESI+ mode using the following settings for the ion source and mass 
spectrometer: curtain gas 30 psi, spraying gas 50 psi, drying gas 50 psi, drying gas temperature 
of 500 °C. The declustering potential was 80 V under full scan mode. Mass range was set as 50-
300 amu. Atenolol was analyzed in the multiple reaction monitoring (MRM) mode at transition 
ions of m/z 267→190 for confirmation and m/z 267→145 for quantification. The possible 
biodegradation products were identified through careful screening in the full scan chromatogram 
followed by spectrum analysis based on nitrogen rule and the existence of the peak [m+Na], etc. 
Tentative structures of biodegradation products were elucidated using the product ion scan mode 
(MS2) and sequential fragmentation using the ion trap.  
The ammonium concentrations were analyzed using a Lachat QuikChem8000 Flow 
Injection Analyzer (Lachat Instrument, Milwaukee) with the concentration profiles provided in 
Figure S1 in SI. No significant nitrite accumulation was observed (less than 1 mg L-1) during 
experiments, which suggests nitration reactions were not relevant [28]. Nitrate concentration was 
at similar level with the SBR effluent (up to 1000 mg L-1). The mixed liquid suspended solid 
(MLSS) concentration and its volatile fraction (MLVSS) were analyzed in triplicate according to 
the standard methods [29]. 
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3. Results and Discussion 
 
3.1 Control experiments 
The abiotic control experiment demonstrated a nearly constant trend of atenolol without 
formation of any transformation products during the 240 h experimental period (Figure 1d). 
Although autoclave might alter the structure of the sludge and affect the sorption capacity of the 
biomass, it could completely inactivate the biomass compared with the method using NaN3 [30]. 
The contribution of sorption to removal of atenolol was negligible in accordance with the 
previously reported low sorption coefficient KD (0.04) and low octanol-water partition 
coefficient Log KOW (0.16) of atenolol [31, 32]. Hydrolytic control showed that the atenolol 
concentration remained nearly constant, which was also supported by the fact that no products 
were detected (Figure S2 in SI). Given the low value of Henry’s Law coefficient of atenolol 
(1.37×10-18 atm m3 mol-1) [33], pH control and the exclusion of light in batch experiments, 
microbial biodegradation of atenolol was the major removal pathway in batch experiments. 
 
3.2 Atenolol biodegradation with ammonia oxidation 
Figure 1a illustrates the decrease of atenolol from an initial concentration of 15 mg L-1 and 
formation of its biodegradation products in the presence of ammonium. The concentration of 
atenolol decreased continuously with approximately 50% transformed by the end of the 240 h 
experiments. The observed trend did not follow a typical first order process and there was no 
linear correlation relationship between ln(C/C0) (C, atenolol concentration; C0, initial atenolol 
concentration) and t (time) for 240 h, probably influenced by ammonia oxidizing activity and 
inhibition from atenolol or its products. Therefore, non-linear regression analysis of atenolol 
  
 
10
concentration profile was performed as shown in Figure S3a in SI. At time 0, 24, 48 and 72 h, 
the atenolol biodegradation rates were calculated as 0.088, 0.061, 0.043 and 0.03 mg atenolol 
gVSS-1 h-1, respectively. The pseudo-first order kinetics analysis for first 96 h indicated a 
degradation constant of 0.07 L gSS-1 d-1. It is lower than the reported values (1.1-1.9 L gSS-1 d-1) in 
the literatures [34], likely due to the unaccustomed sludge to atenolol in this study. It is expected 
that the long-term adaption of the nitrifying culture to atenolol presence will significantly 
enhance its degradation capacity, as confirmed in previous study regarding pharmaceutical 
degradation using nitrifying sludge [35]. Ammonia oxidation rate was calculated based on the 
amounts of ammonium added and the measured NH4+-N concentration at each sampling time. 
The fact that atenolol biodegradation rate decreased with the decreasing ammonia oxidation rate 
(data shown in Figure 2a) was likely due to the substrate competition with ammonium [23] or 
inhibition by the more toxic biodegradation products [36]. The competition for active AMO sites 
could result in decreasing degradation rates of both substrates. Atenolol inhibition on 
nitrification rate was associated with a lower inhibition constant (~4-33 nM), suggesting a 
greater affinity of AMO for atenolol [23]. The biotransformation products (for example phenol, 
transformed from benzene) might also inhibit AOB activity [37]. 
Figure 2b illustrates a positive linear relationship between ammonia oxidation rate and 
atenolol biodegradation rate. Such a positive correlation was also reported for 17α-
ethinylestradiol [14]. This supported the cometabolic biodegradation of atenolol in the presence 
of ammonium [12], likely mediated by the enriched nitrifying culture through the non-specific 
enzyme AMO [10, 38-40]. As the ammonium concentration was controlled nearly constant in the 
experiments with ammonia oxidation, the ratio of atenolol to ammonia was decreasing due to the 
decreased atenolol concentration during the time course. The positive relationship between 
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atenolol degradation rate and ammonia oxidation rate would thus be valid as the ratio of atenolol 
to ammonia was between 0.006 and 0.017 in our experiments. The positive correlation between 
modeled atenolol degradation rate and ammonia oxidation rate after 240 h (orange dots in Figure 
2b, based on the calculation using the model in Figure S3a) further confirmed the possible wide 
range of application for such relationship at different atenolol to ammonia ratios. However, the 
ratio range for the positive relationship in Figure 2b was confirmed to reside in the studied 
experimental conditions, with the further verification being required for lower atenolol 
concentration or different atenolol to ammonia ratios. On the other hand, the correlation might be 
present at the different slope if applying the modest concentration of atenolol, given the 
inhibition from studied high concentration of atenolol on ammonia oxidation rate. 
Simultaneously with the decrease in atenolol concentration (Figure 1a), four new peaks 
appeared, at retention times of 11.12 (P267), 2.92 (P117), 5.25 (P167) and 3.89 min (P227) 
(Figure S4 in SI). The structural elucidation process is described in the following section 3.5. 
The formation of biodegradation products of atenolol was firstly determined qualitatively, using 
the peak areas of the extracted ion chromatograms (A), normalized to the initial peak area of 
atenolol (A0). As shown in Figure 1a, the product P267 was formed continuously until the end of 
the experiment (240 h). As the reference standard for this compound (atenolol acid) is available, 
its concentration was then quantified, which was determined to increase up to 1.3 mg L-1 (8.6% 
of conversion from initial atenolol concentration) at the end of the experiment. The products 
P117 (molecular ion at m/z 118) and P167 (molecular ion at m/z 168) were quantified to increase 
to 37.4 µg L-1 and 97.6 µg L-1 at the end of the experiment (based on the purchased standards 
after structural identification). In the presence of ammonium another product P227 was also 
observed. Its molecular ion m/z 228 had very low signal intensity, with a normalized peak area of 
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only 2% relative to the initial peak area of atenolol. 
 
3.3 Atenolol biodegradation without ammonia oxidation 
Figure 1b represents a decrease in atenolol concentration with 40% removal at the end of the 
experiment (240 h) in the absence of ammonium, which was lower than the removal obtained in 
the batch experiments with ammonia oxidation (50%). The atenolol biodegradation rate (0.023 
mg atenolol gVSS-1 h-1, Figure S3b in SI) was also lower than the values in the presence of 
ammonium during higher ammonia oxidation rate, confirming the potential role of cometabolism 
in atenolol biodegradation by the enriched nitrifying culture.  
Without the presence of ammonium, AOB lacked an important growth substrate to support 
their growth and energy consumption and enzyme synthesis, therefore leading to non-
cometabolic biodegradation of atenolol. Under such conditions, some pharmaceuticals could be 
utilized as sole substrates for carbon and energy source following various metabolic 
biodegradation pathways, mostly conducted by heterotrophs [15, 16].  
During atenolol biodegradation in the absence of ammonium, two new peaks were detected 
at m/z 268 (P267, atenolol acid) and a low intensity peak at m/z 228 (P227). Atenolol acid 
seemed to be formed in higher amounts than during biodegradation in the presence of 
ammonium, which could be probably due to the formation of P117 and P167 in the latter case. 
The concentration of P267 reached 2.9 mg L-1 at the end of the experiment. On the other hand, 
the signal intensity of the molecular ion at m/z 228 was very low (<2%) (Figure 1b). 
 
3.4 Role of heterotrophs in atenolol biodegradation 
Figure 1c illustrates a decrease in atenolol concentration (at the degradation rate of -0.024 
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mg atenolol gVSS-1 h-1, Figure S3c) and formation of product P267 (atenolol acid), which was the 
only product identified in the presence of ATU. The removal efficiency of atenolol over the 240 
h experimental period was 39%, similar to the removal obtained in the absence of ammonium. 
As the ammonium released from cell lysis process during bacterial decay was minor, 
cometabolic biodegradation by AOB without addition of ammonium would not contribute to 
atenolol biodegradation significantly. Therefore, non-cometabolism by AOB was negligible and 
biodegradation by heterotrophs mainly contributed to the removal of atenolol in the absence of 
ammonium, which can be confirmed from the similar atenolol removal efficiencies when AOB 
activity was inhibited by ATU (Figures 1b and 1c). In the presence of ATU, ammonia oxidation 
was inhibited and atenolol biodegradation rate was calculated as 0.028 mg atenolol gVSS-1 h-1, 
which was constant during the time course. Therefore, the contribution of heterotrophs would not 
change significantly during atenolol biodegradation and thus would not affect the linear 
relationship between atenolol biodegradation rate and ammonia oxidation rate in the presence of 
ammonium (Figure 2b), which could also be confirmed from the approximately same slope in 
the corresponding relationship subtracting the contribution by heterotrophs (Figure S5). 
However, the accumulation of P267 reached 1.7 mg L-1 at the end of the experiment in the 
presence of ATU, which was lower than the value of 2.9 mg L-1 in the absence of ammonium. 
Based on these observations (Figures 1b and 1c), P267 could be possibly formed through 
atenolol biodegradation by both AOB and heterotrophs. 
The atenolol biodegradation with ammonia oxidation and with the addition of ATU further 
proved the role of AOB and heterotrophs in pharmaceutical biodegradation [41]. Previously, 
same biotransformation products of EE2 were formed in the biodegradation experiments by 
either AOB or heterotrophs [41], whereas the metabolic type had a significant influence in the 
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biotransformation products and pathways of atenolol in this study (detailed in the following 
sections). 
 
3.5 Structural elucidation of biodegradation products 
Based on the analysis of their full scan spectra, no biotransformation products were detected 
in the atenolol standard solution without biodegradation as well as in the enriched nitrifying 
biomass sample without the addition of atenolol, respectively (Figure S6). Furthermore, the 
qualitative profiles of P117, P167, P227 and P267 showed a gradual increase trend during the 
time course (Figure 1). Therefore, the formation of products P117, P167, P227 and P267 should 
be solely produced from atenolol biodegradation. 
The chemical structures of these products were elucidated through analysis of their product 
ion scan mass spectrum and comparison with the available standard. Briefly, their structures 
were proposed based on these fragment ions and the structural information of atenolol followed 
by confirmation with the standards. 
The most abundant fragment ions detected in the MS2 spectrum of atenolol (molecular ion 
m/z 267) were m/z 190 and 145 (Figure S7a). Fragment ion m/z 190 was formed by the loss of 77 
Da from the molecular ion, characteristic for β-blockers bearing the –NH-CH(CH3)2 side chain 
[42]. Further loss of ammonia and CO followed by an intramolecular cyclization yielded 
fragment ion m/z 145. A similar fragmentation pattern was observed for the biodegradation 
product P267, with a molecular ion m/z 268 (Figure S7b). Comparing with the MS2 spectrum of 
the standard solution of atenolol acid (Figure S8a), it could be confirmed based on the same 
fragment ions and fragmentation pattern that the product P267 was atenolol acid in this work. 
Product ion spectra of atenolol and atenolol acid have been described in previous studies as well 
  
 
15
as the structural identification process of the transformation products [22, 43]. However, to date 
only one biodegradation product, i.e., atenolol acid (P267), has been identified in the 
biodegradation of atenolol by conventional activated sludge, membrane bioreactor sludge or 
activated sludge from a full-scale aerobic nitrification reactor [22, 44]. In this study, P267 
formation was likely due to the contribution by both AOB and heterotrophs. This joint 
contribution was also previously confirmed from the formation of the biodegradation products of 
17α-ethinylestradiol in enriched nitrifying cultures [41]. As heterotrophs in the enriched 
nitrifying sludge might live on more complex carbon source such as decaying cells, the products 
formed by heterotrophs in other cultures (e.g. WWTP sludge) may be different, which deserves 
further research. 
MS2 spectrum of molecular ion m/z 118 (product P117) is shown in Figure 3a. Two 
fragment ions were detected at m/z 58 and m/z 59, presumably formed by the loss of 
isopropylamine and isopropanol, respectively. Further fragmentation of fragment ions m/z 58 and 
m/z 59 did not show any new signals in the mass spectrum of P117. In comparison with the 
standard spectrum in Figure S8b, product P117 could be identified as 1-isopropylamino-2-
propanol. Collision induced dissociation of the molecular ion at m/z 168 (P167) resulted in 
fragment ions m/z 151, m/z 133 and m/z 107 (Figure 3b). Formation of fragment ion m/z 151 was 
assigned to the loss of ammonia from the molecular ion m/z 168. Further fragmentation of m/z 
151 led to a loss of water to form m/z 133, and further cleavage of acetylene (C2H2) to yield a 
signal at m/z 107. Based on the obtained information and the spectrum of the standard in Figure 
S8c, P167 was assigned to 1-amino-3-phenoxy-2-propanol. The structure of P227 could not be 
accurately identified using the MS2 experiments due to the very low signal intensity of the 
molecular ion m/z 228. Based on its MS2 spectrum presented in Figure 3c, molecular ion m/z 228 
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underwent two consecutive losses of 18 Da to form fragment ions m/z 210 and m/z 192. 
According to the nitrogen rule, P227 contained one nitrogen atom and may have been formed 
through amide-bond hydrolysis to carboxylic acid, similar to the product P267. Additional 
analytical methods including accurate mass measurements are required for accurate identification 
of P227. 
The formation of additional products P117, P167 and P227 was firstly reported in this study, 
which could be explained by the constant ammonium feed favoring cometabolic biodegradation 
by nitrifying cultures. AOB-induced cometabolic biodegradation led to the production of P117 
and P167 compared with the biodegradation in absence of ammonium, indicating the 
cometabolism could affect the formation of biodegradation products of pharmaceuticals. As 
previously reported, bezafibrate, naproxen, ibuprofen and diclofenac were biotransformed only 
by the cometabolic biodegradation [16]. Given that P227 was not found when ATU was added to 
inhibit AOB growth, this biodegradation product may be assigned to AOB instead of 
heterotrophs.  
 
3.6 Biodegradation of atenolol acid in the presence of ammonium 
In order to further confirm the formation of biotransformation products, the follow-up 
experiments were conducted on atenolol acid as the parent compound to study its biodegradation 
pathway in the presence of ammonium. The batch experimental designs were same as those for 
atenolol. Figure 4 shows the qualitative profiles of atenolol acid and its biotransformation 
products during 240 h. After a short period of lag phase, atenolol acid dissipated to the final 
concentration of 9.95 mg L-1 with the removal up to 28%. Three products P117, P167 and P227 
were found from the beginning of the experiments with the increasing trends. As the reference 
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standards for P117 and P167 were available, their final concentrations were quantified as 450.5 
and 96.6 µg L-1, respectively. 
 
3.7 Biodegradation pathways by enriched nitrifying sludge 
Based on the identified products, the possible biodegradation pathway by the enriched 
nitrifying sludge was proposed in Figure 5. It indicated that cometabolic biodegradation by AOB 
would lead to different biotransformation pathways of atenolol (forming P267, P227, P117 and 
P167) compared to its metabolic biodegradation (producing P267 and P227). The main 
biodegradation pathway of atenolol was the hydrolysis of the amide group to its carboxylic 
moiety (P267, atenolol acid) regardless of the presence of ammonium. Microbial-induced 
hydrolysis of atenolol has previously been observed in conventional activated sludge and 
membrane bioreactor as well as activated sludge receiving sanitary sewage [22, 45]. Hydrolysis 
was typical for most amide-containing compounds such as bezafibrate and levetiracetam [16, 45]. 
It can be catalyzed by amidases and proteolytic enzymes [46, 47]. While these enzymes were not 
found in Nitrosomonas eutropaea [48], two genes found in Nitrosomonas eutropha including N-
acetylmuramoyl-L-alanine amidase (Neut_1623) and amidohydrolase-2 (Neut_1622) could favor 
the hydrolysis of the C-N bond of amide groups [49].  
Formation of P227 likely involved the hydrolysis of amide bond. One of human metabolite 
of atenolol was a hydroxylated compound [42, 50]. Although it was not detected in this study, 
the similar hydroxylation at the carbon atom neighboring ether oxygen atom may be part of the 
reactions producing P227. 
P267 likely underwent further transformation through the cleavage of ether bond in the alkyl 
side chain (i.e., formation of P117), and N-dealkylation (loss of isopropyl group) and loss of 
acetamide moiety from the aromatic ring, yielding the product P167 under cometabolic 
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conditions. These pathways were related to AOB activity, which was also confirmed through the 
experiments using P267 (atenolol acid) as the parent compound. The cleavage of ether bond in 
2,4-dichlorophenoxyacetic acid, 4-chloro-2-methylphenoxyacetic acid and 2-
methylphenoxyacetic acid was reported by Alcaligenes eutrophus JMP 134 [51]. Dimethyl ether 
could be cooxidized to form methanol and formaldehyde by an ammonia monooxygenase of 
Nitrosomonas europaea [52]. Although there was not much direct work confirming the same 
bond cleavage as this study (P267 was transformed to P117), it could be speculated that there 
might exist some intermediates formed from the typical ether bond cleavage or that the reported 
bond cleavage in this study was due to cometabolism by AOB. Further research would be 
required to confirm this biochemical reaction. Another β-blocker propranolol also underwent 
dealkylation reaction to produce desisopropylpropranolol in rat, dog and man [53, 54]. Few 
reports were documented for dealkylation on amine group of atenolol by nitrifying bacteria. 
Dealkylation reaction was reported as an important pathway for a variety of amine-containing 
compounds in either the biotransformation system by nitrifying sludge or the mammalian system 
[55]. Previously reported dealkylation of secondary amine occurs in catalysis by monooxygenase 
from Pseudomonas aminovorans, which had the same function as cytochrome P450 or by 
monoamine oxidase-w-Transaminase cascade [56, 57]. Notwithstanding the absence of previous 
direct evidence of AMO on dealkylation, it was suspected that the monooxygenase from AOB 
likely catalyze this biochemical reaction. As for the loss of acetamide group from aromatic ring, 
it also requires more efforts on identifying this reaction in the future. On the other hand, the 
further work on atenolol biodegradation at environmentally concentration also needs to be 
conducted in order to verify the formation of the biodegradation products and the proposed 
biodegradation pathways. 
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4. Conclusions 
In this work, the biodegradation of β-blocker atenolol was investigated using an enriched 
nitrifying culture at controlled ammonium concentration and without ammonium addition. The 
key conclusions are: 
• Atenolol biodegradation was found to be related to ammonia oxidation rate, indicating the 
cometabolism by AOB in the enriched nitrifying sludge. 
• Four compounds including P117, P167, P227 and P267 (atenolol acid) were produced under 
cometabolic condition in the presence of ammonium while only two products P267 and P227 
were formed in the absence of ammonium. 
• P117, P167 and P227 were not reported previously. The chemical structures of P117 and 
P167 were identified as 1-isopropylamino-2-propanol and 1-amino-3-phenoxy-2-propanol. 
• Atenolol was hydroxylated to P267 (atenolol acid) and was converted to P227 regardless of 
the presence of ammonium. Under cometabolic conditions, the biodegradation product P117 
and P167 could be further formed through the cleavage of ether bond in the alkyl side chain 
and N-dealkylation and loss of acetamide moiety, respectively. 
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Figure Legends 
 
Figure 1. Qualitative profiles of atenolol and its biodegradation products in biodegradation 
experiments: (a) in the presence of ammonium, (b) without ammonium addition, (c) with the 
addition of ATU and (d) with autoclaved biomass. Y-axis indicates the peak areas of the 
extracted ion chromatograms of atenolol or its biodegradation products (A) normalized to the 
initial peak area of atenolol (A0). 
 
Figure 2. (a) The calculated ammonia oxidation rate during biodegradation experiments in the 
presence of ammonium and (b) Relationship between ammonia oxidation rate and atenolol 
biodegradation rate (orange dots indicated the modeled values). 
 
Figure 3. Proposed fragmentation pathways of biodegradation products under ESI+ conditions 
derived from MS2 experiments in the QqLIT mass spectrometer: (a) P117, (b) P167 and (c) 
P227. 
 
Figure 4. Qualitative profiles of atenolol acid (P267) and its biotransformation products in 
biodegradation experiments in the presence of ammonium. Y-axis indicates the peak areas of the 
extracted ion chromatograms of atenolol acid or its biotransformation products (A) normalized to 
the initial peak area of atenolol acid (A0). 
 
Figure 5. Proposed biodegradation pathways of atenolol by the enriched nitrifying culture in the 
presence of ammonium as well as in the absence of ammonium. 
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Figure 1. Qualitative profiles of atenolol and its biodegradation products in biodegradation 
experiments: (a) in the presence of ammonium, (b) without ammonium addition, (c) with the 
addition of ATU and (d) with autoclaved biomass. Y-axis indicates the peak areas of the 
extracted ion chromatograms of atenolol or its biodegradation products (A) normalized to the 
initial peak area of atenolol (A0). 
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Figure 2. (a) The calculated ammonia oxidation rate during biodegradation experiments in the 
presence of ammonium and (b) Relationship between ammonia oxidation rate and atenolol 
biodegradation rate (orange dots indicated the modeled values). 
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Figure 3. Proposed fragmentation pathways of biodegradation products under ESI+ conditions 
derived from MS2 experiments in the QqLIT mass spectrometer: (a) P117, (b) P167 and (c) 
P227. 
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Figure 4. Qualitative profiles of atenolol acid (P267) and its biotransformation products in 
biodegradation experiments in the presence of ammonium. Y-axis indicates the peak areas of the 
extracted ion chromatograms of atenolol acid or its biotransformation products (A) normalized to 
the initial peak area of atenolol acid (A0). 
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Figure 5. Proposed biodegradation pathways of atenolol by the enriched nitrifying culture in the 
presence of ammonium as well as in the absence of ammonium. 
 
 
  
 
31
Highlights 
 Atenolol biodegradation was found to be related to ammonia oxidation rate. 
 Four products P117, P167, P227 and P267 were produced in the presence of ammonium. 
 Two products P267 and P227 were formed in the absence of ammonium. 
 The chemical structures of products P117, P167 and P267 were identified. 
 A two-step biodegradation pathway of atenolol by enriched nitrifying culture is revealed. 
 
